NCT00258765View on ClinicalTrials.gov

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Zoledronic Acid

DRUG

Docetaxel

Trial Locations (1)

Unknown

Novartis Investigative Site, Sydney

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY